Understanding how tau spreads in Alzheimer's disease that affects more than just memory

Spreading Tau Pathology in Non-Amnestic Alzheimer's Disease

NIH-funded research University of Pennsylvania · NIH-11139447

This project aims to understand how a harmful protein called tau spreads in the brains of people with Alzheimer's disease, especially when their symptoms don't primarily involve memory loss.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania NIH-funded
Lab location1 site (Philadelphia, United States)
Project IDNIH-11139447 on NIH RePORTER

What this research studies

We are looking into how a specific protein, called tau, moves through the brain in people with Alzheimer's disease, particularly those whose symptoms affect areas like vision, language, or movement rather than just memory. Our team will use advanced brain imaging techniques, including PET scans to track tau and MRI scans to look at the brain's white matter connections. By comparing these images over time, we hope to discover if changes in these connections predict how tau spreads from one brain region to another. This work could help us better understand the different ways Alzheimer's disease affects people and potentially lead to new ways to slow its progression.

Who could benefit from this research

Good fit: This research is relevant for adults aged 21 and older who have been diagnosed with Alzheimer's disease, particularly those with non-memory-related symptoms.

Not a fit: Patients without Alzheimer's disease or those whose condition is not related to tau pathology would not directly benefit from this specific research.

Why it matters

Potential benefit: If successful, this work could lead to a better understanding of how Alzheimer's disease progresses in different individuals, potentially guiding the development of more targeted treatments.

How similar studies have performed: While the idea of tau spreading along brain connections has been explored in animal models, this project aims to test this specific mechanism in humans using advanced imaging, representing a novel approach in this context.

Where this research is happening

Philadelphia, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.